T. Rowe Price Associates’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.95M | Sell |
|
|||||
|
2025
Q1 | $9.11M | Buy |
|
|||||
|
2024
Q4 | $13.7M | Sell |
|
|||||
|
2024
Q3 | $37.4M | Buy |
|
|||||
|
2024
Q2 | $32.9M | Sell |
|
|||||
|
2024
Q1 | $57.1M | Sell |
|
|||||
|
2023
Q4 | $94.5M | Sell |
|
|||||
|
2023
Q3 | $72.4M | Buy |
|
|||||
|
2023
Q2 | $105M | Buy |
|
|||||
|
2023
Q1 | $113M | Buy |
|
|||||
|
2022
Q4 | $67.1M | Sell |
|
|||||
|
2022
Q3 | $102M | Sell |
|
|||||
|
2022
Q2 | $88.8M | Buy |
|
|||||
|
2022
Q1 | $150M | Buy |
|
|||||
|
2021
Q4 | $128M | Buy |
|
|||||
|
2021
Q3 | $51M | Buy |
|
|||||
|
2021
Q2 | $42.9M | Sell |
|
|||||
|
2021
Q1 | $52M | Buy |
|
|||||
|
2020
Q4 | $32.1M | Sell |
|
|||||
|
2020
Q3 | $33.5M | Buy |
|